drugset / Trial / NCT02967393
Influenza Vaccine Feasibility Study in Children With Persistent Asthma
Phase 4
Completed
40 enrolled
Vanderbilt University Medical Center
Centers for Disease Control and Prevention · collabChildren's Hospital Medical Center, Cincinnati · collabDuke University · collab
RandomizedParallel-groupOpen-labelOther
Summary
This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
Timeline
- Start
- 2016-10-10
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flucelvax | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | Intramuscular |